Recommendations on the use of live, attenuated influenza vaccine (FluMist®): supplemental statement on seasonal influenza vaccine for 2011-2012
Author:
- This Statement Was Prepared And Approved By NaciTNThis Statement Was Prepared And Approved By Naci
- 1 November 2011
- journal article
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Canada Communicable Disease Report
- Vol. 37 (ACS-7) , 1-77
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 yearsVaccine, 2011
- A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and olderVaccine, 2011
- A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young childrenVaccine, 2009
- Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trialsVaccine, 2009
- Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated VaccinesThe Journal of Infectious Diseases, 2008
- Direct and Total Effectiveness of the Intranasal, Live-Attenuated, Trivalent Cold-Adapted Influenza Virus Vaccine Against the 2000-2001 Influenza A(H1N1) and B Epidemic in Healthy ChildrenArchives of Pediatrics & Adolescent Medicine, 2004
- Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young childrenThe Pediatric Infectious Disease Journal, 2001
- Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold‐Adapted, Administered to Human Immunodeficiency Virus (HIV)–Infected and Non–HIV‐Infected AdultsThe Journal of Infectious Diseases, 2000
- Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.1996
- Immunization of Infants and Young Children with Live Attenuated Trivalent Cold-Recombinant Influenza A H1N1, H3N2, and B VaccineThe Journal of Infectious Diseases, 1992